Financial News

The Near-Term Setup For Biogen Has Positive Risk/Reward Written All Over It

By: via Benzinga
While risks to the stock still remain, UBS has upgraded Biogen Inc (NASDAQ: BIIB) from Sell to Neutral and has raised its price target ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback